SCHAERR JAFFE LLP

Lobbying for CELLPHIRE THERAPEUTICS, INC. · biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Blood platelet technology and the Strategic National Stockpile

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem